TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionomen AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,537
|
799
|
776 |
| Financial expenses |
1
|
1
|
1 |
| Earnings before taxes |
275
|
101
|
-5 |
| EBITDA |
276
|
103
|
-3 |
| Total assets |
454
|
291
|
494 |
| Current assets |
452
|
287
|
492 |
| Current liabilities |
93
|
160
|
185 |
| Equity capital |
338
|
120
|
298 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
2
|
2
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
74.4%
|
41.2%
|
60.3% |
| Turnover per employee |
768
|
400
|
259 |
| Profit as a percentage of turnover |
17.9%
|
12.6%
|
-0.6% |
| Return on assets (ROA) |
60.8%
|
35.1%
|
-0.8% |
| Current ratio |
486.0%
|
179.4%
|
265.9% |
| Return on equity (ROE) |
81.4%
|
84.2%
|
-1.7% |
| Change turnover |
735
|
86
|
48 |
| Change turnover % |
92%
|
12%
|
7% |
| Chg. No. of employees |
0
|
-1
|
0 |
| Chg. No. of employees % |
0%
|
-33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.